1. Home
  2. NVDA vs AZN Comparison

NVDA vs AZN Comparison

Compare NVDA & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVIDIA Corporation

NVDA

NVIDIA Corporation

HOLD

Current Price

$180.36

Market Cap

4.5T

Sector

Technology

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$189.65

Market Cap

285.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVDA
AZN
Founded
1993
1992
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5T
285.7B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
NVDA
AZN
Price
$180.36
$189.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
38
1
Target Price
$263.29
N/A
AVG Volume (30 Days)
138.3M
1.8M
Earning Date
05-26-2026
01-01-0001
Dividend Yield
0.02%
1.66%
EPS Growth
66.67
N/A
EPS
4.90
N/A
Revenue
$215,938,000,000.00
N/A
Revenue This Year
$67.04
$10.13
Revenue Next Year
$29.67
$6.21
P/E Ratio
$37.38
$31.91
Revenue Growth
65.47
N/A
52 Week Low
$86.63
$61.24
52 Week High
$212.19
$212.71

Technical Indicators

Market Signals
Indicator
NVDA
AZN
Relative Strength Index (RSI) 44.95 54.67
Support Level $177.57 $89.28
Resistance Level $184.36 $211.32
Average True Range (ATR) 5.33 3.22
MACD -0.32 -5.15
Stochastic Oscillator 23.64 1.66

Price Performance

Historical Comparison
NVDA
AZN

About NVDA NVIDIA Corporation

Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence to run large language models. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Share on Social Networks: